IFRX vs VRTX: Which Stock is Better?

Side-by-side comparison of Inflarx Nv and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

IFRX

Inflarx Nv

$1.07

VRTX

Vertex Pharmaceuticals Inc

$444.28

Key Metrics Comparison

MetricIFRXVRTXWinner
Market Cap$77.35M$111.93BVRTX
P/E RatioN/A28.74VRTX
EPS (TTM)$N/A$15.31VRTX
Revenue Growth-0.8%0.1%VRTX
Gross Margin-24677.9%53.7%VRTX

Analyze IFRX

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IFRX or VRTX a better investment?

Comparing IFRX and VRTX: Inflarx Nv has a market cap of $77.35M while Vertex Pharmaceuticals Inc has $111.93B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IFRX and VRTX?

IFRX (Inflarx Nv) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IFRX or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IFRX or VRTX?

VRTX has higher revenue growth at 0.1% vs -0.8% for IFRX.

Which company is more profitable: IFRX or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -24677.9% for IFRX.

Which is the larger company: IFRX or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $111.93B compared to $77.35M for IFRX.

Should I buy IFRX or VRTX in 2026?

Both IFRX and VRTX have investment merit. IFRX trades at $1.07 while VRTX trades at $444.28. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IFRX and VRTX stock?

Key differences: Market Cap ($77.35M vs $111.93B), P/E Ratio (N/A vs 28.7x), Revenue Growth (-0.8% vs 0.1%), Gross Margin (-24677.9% vs 53.7%).

Popular Stock Comparisons